secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bluejay Diagnostics, Inc. (BJDX)
CIK:        0001704287
Form:       8-K
Filed at:   2026-06-02T10:30:41+00:00
Accession:  0001213900-26-063767
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bluejay Diagnostics partners with Argonaut for US-based Symphony platform manufacturing
--------------------------------------------------------------------------------

- Agreement with Argonaut for full manufacturing services (planning, sourcing, formulation, filling, QC, distribution) for IL-6 tests.
- Partnership aims to establish scalable US-based manufacturing, reducing overseas dependency and import tariff risks.
- Supports Symphony platform clinical programs (SYMON-I, II, III) and future commercialization in critical care near-patient testing.
- No financial terms disclosed; platform remains investigational under US law.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1704287/000121390026063767/0001213900-26-063767-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1704287/000121390026063767/ea0293118-8k_bluejay.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-063767

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer